Please login to the form below

Not currently logged in
Email:
Password:

Former AstraZeneca man Graham Walker joins Idea Pharma

Will work with product teams to bridge gap between clinical and commercial

Graham Walker - IDEA PharmaDr Graham Walker has joined product design consultants Idea Pharma as a member of its Ideation team.

He will work alongside global product teams to form strategies for compounds in phase II development in an attempt to link more closely the clinical and commercial stages of a drug's lifespan.

Dr Walker's previous experience in the field includes two years at AstraZeneca between 2009 and 2010 where he served as therapy area physician - oncology.

During his time at the pharma company he was part of the team that helped bring the non small cell lung cancer (NSCLC) drug Iressa (gefitinib) to market.

Dr Walker later left AZ to join Napp Pharmacueuticals in the UK where he worked on the company's respiratory products.

Prior to his career in the industry, Dr Walker served in the clinical environment at several UK hospitals.

He was also director of his own technology company, HealthTrade, from 2001 to 2008, which used the latest technological advancements to provide healthcare solutions.

“My career to date has been built on spearheading innovation within many commercial organisations,” said Dr Walker, “so it makes complete sense to join Idea, a company that is clearly leading the industry in ensuring innovative drugs get to market in great shape. I look forward to tackling the challenges that lie ahead.”

Mike Rea, Idea's CEO, commented: “We were really lucky to find Graham. He was about to accept a great position with one of the 'top 5' when we met.”

14th May 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Planning your clinical trial? Why you need to engage patients sooner
It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...

Infographics